文献速递冠心病外科瓣膜外科心外重症与机械循环支持

同期心脏手术中行房颤消融改善远期生存

Atrial fibrillation ablation improves late survival after concomitant cardiac surgery.
PubMed 文献 · J Thorac Cardiovasc Surg · 2022-05-14

基于HEIST登记研究,纳入2010至2021年波兰、荷兰和意大利8家三级中心20765例术前房颤接受正中开胸心脏手术的成人患者,其中2755例(13.4%)同期行外科消融。倾向评分匹配后,外科消融与远期死亡率降低16%相关(HR 0.84,95%CI 0.75-0.94,P=.003)。

要点

  • 多中心回顾性倾向匹配研究显示,同期外科消融与远期死亡率降低16%相关(HR 0.84,95%CI 0.75-0.94,P=.003)。
  • 外科消融组患者更年轻(平均64.5±9.0岁 vs 68.7±16.0岁,P<.001)且风险更低(EuroSCORE II 4.1 vs 5.7,P<.001)。
  • 二尖瓣干预(瓣膜修复或置换加三尖瓣干预)中外科消融率最高(25.2%),单纯冠状动脉旁路移植术最低(6.2%)。

核心结论

  • 在多中心回顾性倾向匹配研究中,同期外科消融与其他心脏手术合并进行与远期生存改善相关,且不受基线手术风险影响。

研究设计与样本

  • 本研究为HEIST登记研究的报告,纳入2010至2021年间在波兰、荷兰和意大利8家三级中心接受常规正中开胸心脏手术的20765例术前房颤成人患者(62%为男性)。
  • 采用Cox比例风险模型计算,并使用倾向评分匹配以最小化基线特征差异。

主要发现

  • 纳入患者中2755例(13.4%)接受了房颤外科消融。
  • 外科消融率最高见于二尖瓣干预(二尖瓣修复或置换加三尖瓣干预,25.2%),最低见于单纯冠状动脉旁路移植术(6.2%)。
  • 外科消融组患者更年轻(平均年龄64.5±9.0岁 vs 68.7±16.0岁;P<.001)且风险更低(平均EuroSCORE II 4.1 vs 5.7;P<.001)。
  • 在11年研究期间,外科消融与死亡率降低相关(HR 0.57;95%CI 0.52-0.62;P<.001)。
  • 倾向匹配后识别出2750对基线特征相似的患者,外科消融与16%的死亡率下降相关(HR 0.84;95%CI 0.75-0.94;P=.003)。

局限性

  • 本研究为多中心回顾性研究,原文未报告其他局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Preoperative atrial fibrillation (AF) increases risk of stroke, heart failure, and all-cause mortality after cardiac surgery. Despite encouraging results and guideline recommendations, surgical ablation (SA) for AF concomitant with other heart surgery remains low. In the current study we aimed to address the long-term mortality after SA concomitant with cardiac surgery. METHODS: This report pertains to the HEart surgery In atrial fibrillation and Supraventricular Tachycardia (HEIST) registry. We identified 20,765 adult patients (62% male) with preoperative AF who underwent conventional sternotomy heart surgery between 2010 and 2021 in 8 tertiary centers in Poland, Netherlands, and Italy. We used Cox proportional hazards models for computations and propensity score matching to minimize differences in baseline characteristics. RESULTS: Of included patients, 2755 (13.4%) underwent SA for AF. The highest rates of SA were observed for mitral interventions (mitral valve repair or replacement and tricuspid intervention, 25.2%), lowest for isolated coronary artery bypass grafting (6.2%). Patients in the SA group were younger (mean age 64.5 ± 9.0 years vs 68.7 ± 16.0 years; P < .001) and lower risk (mean European System for Cardiac Operative Risk Evaluation [EuroSCORE] II, 4.1 vs 5.7; P < .001). During the 11-year study period, there was a mortality reduction associated with SA (hazard ratio, 0.57; 95% CI, 0.52-0.62; P < .001). After propensity matching, 2750 pairs with similar baseline characteristics were identified. SA was associated with 16% mortality decline (hazard ratio, 0.84; 95% CI, 0.75-0.94; P = .003). CONCLUSIONS: In this multicenter, retrospective, propensity matched study, SA concomitant with other cardiac surgery was associated with improved long-term survival regardless of baseline surgical risk.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Kowalewski M, Pasierski M, Kołodziejczak M, et al. Atrial fibrillation ablation improves late survival after concomitant cardiac surgery. J Thorac Cardiovasc Surg. 2022. PMID: 35965139. doi:10.1016/j.jtcvs.2022.04.035

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。